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In Brief
Quantitative assessment of intracellular
metabolism requires measuring the
enzyme-to-enzyme flow of metabolites.
Mitochondria have multiple nodes where
metabolites intersect, scramble, and
diverge, complicating isotope labeling.
Alves et al. use LC-MS/MS to decipher
step-wise position-specific transfer of
13C coming from glucose into subsequent
metabolites through glycolysis and
around the TCA cycle.
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Mass isotopomer multi-ordinate spectral analysis
(MIMOSA) is a step-wise flux analysis platform to
measure discrete glycolytic and mitochondrial meta-
bolic rates. Importantly, direct citrate synthesis rates
were obtained by deconvolving the mass spectra
generated from [U-13C6]-D-glucose labeling for posi-
tion-specific enrichments of mitochondrial acetyl-
CoA, oxaloacetate, and citrate. Comprehensive
steady-state and dynamic analyses of key metabolic
rates (pyruvate dehydrogenase, b-oxidation, pyru-
vate carboxylase, isocitrate dehydrogenase, and
PEP/pyruvate cycling) were calculated from the
position-specific transfer of 13C from sequential pre-
cursors to their products. Important limitations of
previous techniques were identified. In INS-1 cells,
citrate synthase rates correlated with both insulin
secretion and oxygen consumption. Pyruvate car-
boxylase rates were substantially lower than previ-
ously reported but showed the highest fold change
in response to glucose stimulation. In conclusion,
MIMOSAmeasures keymetabolic rates from the pre-
cursor/product position-specific transfer of 13C-label
between metabolites and has broad applicability to
any glucose-oxidizing cell.
INTRODUCTION
During his Nobel banquet address in 1953, Sir Hans Krebs
modestly understated the importance of citric acid cycle meta-
bolism, saying, ‘‘I amconvinced than anunderstanding of thepro-
cess of energy production will eventually help us in solving some
of the practical problems of medicine’’ (http://www.nobelprize.
org/nobel_prizes/medicine/laureates/1953/krebs-speech.html).
From bacteria to humans, the cores of both oxidative and syn-
thetic metabolism revolve around the sequential enzymatic reac-
tions of the citric acid cycle (tricarboxylic acid [TCA] or Krebs
cycle). It is the cantus firmus upon which the rest of organismal
metabolism is composed. Eachmeasure of the cycle is described936 Cell Metabolism 22, 936–947, November 3, 2015 ª2015 Elsevierby the ligation of oxaloacetate (OAA) with acetyl coenzyme A (Ac-
CoA) in order to generate citrate by the mitochondrial matrix
enzyme citrate synthase (CS).
Considered in its entirety, the TCA cycle is primarily oxidative.
As such, the TCA rate often experimentally correlates to varying
degrees with O2 consumption, CO2 production, mitochondrial
membrane potential, and ATP synthesis. However, factors such
as ROS production, proton leak, ion translocation, and citrate
lyase activity divert the output of citrate synthesis away from
oxidative phosphorylation. Similarly,metabolism flowing through
partial segments of the cycle (e.g., into synthetic, signaling, or en-
ergy producing pathways) via exchange, entrance (anaplerosis),
export (cataplerosis), or futile cycles may have little or no linkage
with the more traditional oxidative readouts or even CS. Various
isotope-labeling methods have estimated isolated features of
the TCA cycle from the interpretation of one or a few metabolite
tracers (Bequette et al., 2006). For instance, hyperpolarized
NMR has detected positional transfer of label from [1,2-13C2]py-
ruvate to glutamate via both oxidative and anaplerotic pathways
(Chen et al., 2012). While qualitatively informative, these tech-
niques may miss certain aspects of mitochondrial metabolism
in part because of unexpected dilutions coming from unlabeled
metabolites. Amore comprehensive integrated pathway analysis
is needed that can account for segmental as well as multi-turn
TCAfluxes to allow the quantification of thepleiotropicmitochon-
drialmetabolic pathways, especially in tissues that are not strictly
oxidative.
An important early advance in metabolic flux tracking was
the use of NMR-based 13C spin-labels for isotopomer analysis
(de Graaf et al., 2011; Schryer et al., 2009). Here a major strength
is the ability to determine precise position-specific labeling
(isotopomeric) patterns of a metabolite. Such data inform the
modeling of intracellular metabolic rates from 13C-13C J-cou-
pling patterns that identify the enrichments of neighboring car-
bons. Recently, there has been an increase in the use of 13C
and other mass-labels to chase metabolic fluxes through mass
isotopologue (position-independent) analysis (Buescher et al.,
2015). Isotopomer analysis, however, need not be limited to
NMR, and strategic fragmentation of metabolites can yield posi-
tion-specific labeling of some metabolites. Key advantages of
mass spectroscopy (MS) include simultaneous measurement
of both labeled and unlabeled metabolites, improved sensitivity,
and the potential to analyze individual isotopomers.Inc.
Figure 1. Citrate Isotopomer Analysis
(A) Isotopomers generated during the 1st (red), 2nd (orange), and 3rd (yellow) turn of the TCA cycle. Citrate isotopomers were grouped into families depending on
whether the label is originated from PDH flux only (Cita, Citf, Citb, Citi, Citd, Cite, and Citk) or from both PDH and PC fluxes (Cith, Citc, Citj, Citg, Citf’, and Citb’).
(B and C) (B) Enrichment time course of the deconvolved citrate isotopomers from PDH flux alone or (C) from both PDH and PC fluxes.
(D) Total PDH (S Cita, f, i, d, h, j) and PC flux (S Cith, c) into citrate.
(E) Measured versus predicted glutamate C2, C3, and C4 NMR multiplets patterns from deconvolved citrate isotopomer data. All data are reported as
mean ± SEM.Here, we present a comprehensive and direct platform to track
the flow of mass isotope labels through the sequential reactions
of glycolysis and the TCA cycle via mass isotopomeric multi-
ordinate spectral analysis (MIMOSA). MIMOSA deciphers the
glucose-dependent changes in oxidative and non-oxidative
metabolic rates in cultured cells.
RESULTS
Isotopomer Analysis
The synthesis of citrate from mitochondrial AcCoA and OAA is
the defining reaction of the TCA cycle. The AcCoA is formed
via the PDH reaction, b-oxidation, the ligation of free acetate,
and/or metabolism of some amino acids. Similarly, the OAA
is formed from the oxidation of malate, the deamination of
aspartate, and/or the carboxylation of pyruvate. Since pyruvate
metabolism generates both AcCoA and OAA, isotope-labeled
pyruvate will therefore impact multiple intersecting reactions
(Figure 1). Citrate carbon 3 (C3) is stereochemically a prochiral
center, and C4,5 and C1,2 are biochemically distinguishable.Cell MThus, C4,5 arise from AcCoA in the Pro-S arm and those from
OAA as the C1,2,3,6 containing the Pro-R carbons. For instance,
metabolism of [U-13C6]glucose generates [U-
13C3]pyruvate (Fig-
ure 1A) that enters the TCA cycle via either PDH (dark blue) or PC
(dark green). The 13C-label can enter as AcCoA and traverse
multiple trips around the TCA cycle (light blue) and recombine
to generate the stoichiometric labeling patterns shown to the
right. Alternatively, if labeled pyruvate is carboxylated, then it
generates the labeling patterns in the left branch. Consequently,
in the presence of labeled substrates, citrate will be embedded
with isotopic information reflecting all of these reactions in pro-
portion to the relative rates they occur. Deconvolving the accu-
mulating isotopomer patterns that ‘‘mark’’ citrate is thus key to
understanding multiple crucial mitochondrial reactions.
Unlike enzymes, the mass spectrometer does not recognize
citrate prochirality during ionization or fragmentation. Neverthe-
less, because of the stoichiometric relationship between iso-
topomer family members (Figure 1A, boxed), the unique solution
was algebraically decrypted from 13C mass label distribution in
citrate (Supplemental Experimental Procedures, S2C; Figuresetabolism 22, 936–947, November 3, 2015 ª2015 Elsevier Inc. 937
Figure 2. Tracking of 13C-Label
(A) [1,2-13C2]Acetyl-CoA (from glutamate MIDA)
compared to its precursor [U-13C3]PEP.
(B–D) Mitochondrial M+2, M+4, and [(1,2,3)
(2,3,4)-13C3] (from PC flux) isotopomer evolution in
OAA, aspartate, and malate.
(E) Incorporation of [U-13C6]glucose into the
glycolytic intermediates fructose-1,6-bis phos-
phate (F1,6bP, M+6), 3-phosphoglycerate (3PG,
M+3), 2-phosphoglycerate (2PG, M+3), PEP(M+3),
and pyruvate (M+3).
(F and G) (F) Evolution of 13C-label from glycolysis
into the TCA cycle through PDH flux and (G)
anaplerotic PC flux. All data are reported as
mean ± SEM.S1A). Figure 1B shows the time course of oxidative glucose
metabolism generating PDH-derived label. The lag in appear-
ance and sequential dilution of 13C-label with subsequent turns
is as expected for repeated cycles (1st cycle [blue] > 2nd cycle
[magenta] > 3rd cycle [red]). A similar pattern emerged when
following citrate through anaplerotic PC carbon labeling (Fig-
ure 1C, 1st cycle [blue] > 2nd cycle [red]). In both cases (Figures
1B and 1C), the enrichments were higher for those families con-
taining labeled PDH carbons (solid lines) compared to unlabeled
(dotted lines) as expected. The summation of all the PDH-con-
taining isotopomers and all the PC-containing isotopomers is
shown in Figure 1D. Since both are derived from the same pyru-
vate pool, it is clear that VPDH is greater than VPC. These data are
in direct contrast to the NMR-based measurements where PC
was estimated to be even higher than PDH (Cline et al., 2004;
Jensen et al., 2006; Lu et al., 2002; Simpson et al., 2006).
In order to understand if the discrepancy between the
MIMOSA and NMR-based flux estimates was from differences
in positional assignments, the MIMOSA citrate isotopomers
were used to predict the 13C-NMR J-coupled multiplet patterns
of glutamate and then directly compared to the measured gluta-
mate NMR spectrum (Figure 1E). NMR did have significantly
higher singlet enrichments relative to MIMOSA. Unlike NMR, a
real strength of the MIMOSA analysis is a more direct natural
abundance correction (since MS directly measures both 13C938 Cell Metabolism 22, 936–947, November 3, 2015 ª2015 Elsevier Inc.and 12C). Labeling patterns were consis-
tent with expected isotope distributions,
and all symmetry rules were obeyed. In
general, the two patterns of glutamate
multiplets were concordant, and the mi-
nor differences observed between the
two techniques were not large enough to
explain the differences in VPC relative to
VPDH.
Mass Isotopomer Distribution
Analysis of Citrate and Glutamate
In addition to the citrate isotopomers, the
positional enrichments of the precursors
to citrate (i.e., the matrix pool of OAA
and AcCoA) are essential to fully assess
CS metabolism. Unfortunately, direct
measurements of these are complicated
by their low abundance, fragmentation complexity, and the
presence in both mitochondrial and cytosolic pools. To circum-
vent these difficulties, AcCoA and OAA isotopomers can be
calculated directly from mass isotopomer distribution analysis
(MIDA) of the enriched products (i.e., citrate or glutamate).
MIDA exploits the binomial relationship encoded into the prod-
uct when two labeled precursors are ligated. This relationship re-
mains discernable even in the setting of dilution of the product by
unlabeled metabolites. Consequently, the isotopomers of OAA
and AcCoA can be determined within the subcellular compart-
ment where the reaction occurs (Supplemental Experimental
Procedures, S3; Table S1).
[1,2-13C2]Acetyl-CoA enrichment was determined from the
glutamate isotopomer data and compared to the [U-13C3]phos-
phoenolpyruvate (PEP) enrichments (Figure 2A). PEP was used
(rather than pyruvate) to avoid contributions from media pyru-
vate or lactate at early time points. Notably, the calculated
[1,2-13C2]AcCoA enrichments were similar to its precursor PEP
at all time points. Identical steady-state [U-13C3]PEP and
[1,2-13C2]AcCoA enrichments indicate a virtual absence of lipid
oxidation in the presence of 9mM glucose and absence of exog-
enous fatty acids.
Similarly, the mitochondrial OAA isotopomers calculated from
citrate MIDA are concordant with the isotopomer kinetics of
aspartate and malate (Figures 2B–2D). In contrast to the OAA
M+2 andM+4 isotopomers, the OAA coming from PC (denoted as
[(1,2,3)(2,3,4)-13C3]OAA) was significantly lower than that for
aspartate (Figure 2D). Delayed trans-mitochondrial shuttle equil-
ibration of aspartate and malate between the cytosol and mito-
chondrial pools suggests caution should be used if aspartate is
surrogated for OAA, particularly in an open system.
Sequential Flux Mapping
Following the addition of labeled glucose, the time-dependent
incorporation of 13C-label into the intermediates of glycolysis
was measured. The glucose enrichment was a square-wave
function that plateaued at 99 atomic percent enrichment
(APE). The glycolytic intermediates approached steady state
within approximately 5 min (Figure 2E). Fructose 1,6-bisphos-
phate (F1,6bP) plateaued at approximately 85% with little or no
difference in final enrichment through glycolysis down to pyru-
vate. Starting with PEP, the carbons could be followed through
PDH and into Pro-S citrate and around the TCA cycle all the
way back to Pro-R citrate after a full turn (denoted as citrate
second turn) (Figure 2F). As expected, progressive delays and
dilutions were observed in sequential reactions. Similarly, PC-
derived carbons flowed from PEP into OAA (via PC) and eventu-
ally into pro-R citrate (via CS) followed by C1,2,3 glutamate
(Figure 2G). Note that despite originating from the same pyruvate
pool, PC-derived OAA had one-eighth the enrichment of AcCoA,
suggesting a minority contribution of PC flux to the overall TCA
cycle.
Steady-State Flux Analysis
The confluences of intersectingmetabolic pathways are the sites
where label dilutions can occur. Such biochemical nodes may
complicate flux determinations, though they contain important
information about the magnitude of one pathway relative to
another. At metabolic and isotopic steady state, the concentra-
tion, flux, and enrichment are constant and were confirmed
experimentally. If only one metabolite flow contributes to a
metabolic pathway, then the ratio of precursor and product po-
sitional enrichments (Fproduct/precursor) should be 1 (Supplemental
Experimental Procedures, S4). A reduction in F between serial
metabolites in a pathway/reaction indicates that unlabeled (or
differently labeled) carbons from an alternative metabolic source
are also contributing to product formation. Such carbon dilutions
within the TCA cycle are considered anaplerotic if they are
balanced by an equivalent cataplerotic outflow at a different
site. In contrast, the label is diluted during an exchange reaction
but is not an indication of an increase in flux because the entry
and exit of a metabolite are balanced and occur at the same
site. For instance, unidirectional entry of glutamate carbons via
glutamate dehydrogenase (GDH) is anaplerotic. The reciprocal
entry and exit of glutamate carbons via rapid equilibration across
transaminase reactions can be considered as an exchange. In
the absence of exogenous acetate, ketones, or branched chain
amino acids, then PDH and b-oxidation are the only relevant po-
tential suppliers of mitochondrial AcCoA. A nearly 50% APE
reduction going from citrate to glutamate is consistent with ex-
change and/or anaplerosis of similar magnitude to VCS at the
level of a-ketoglutarate (aKG) (Figure 2F).
The equations for each of the 52 unique steady-state precur-
sor-product relationships (Fs) across the TCA cycle were solvedCell Mfor the shown individual and grouped reactions (Figure 3A and
S2; Table S2). This comprehensive map identifies discrete car-
bon entry points for oxidative reactions (blue), PC-driven anaple-
rosis (green), PEP/pyruvate cycling (red), and subsequent turns
of the TCA cycle (orange) measured by specific steady-state iso-
topomeric relationships across sequential and serial reactions of
the TCA cycle (Figures 3B–3D).
The >50%dilution of isotopomers between [2,3-13C2] PEP and
[4,5- 13C2]-L-glutamate labeling (FPAcCitG) also indicates a sub-
stantial entry of unlabeled carbon somewhere between these
twometabolites (Figure 3B). In contrast, the small dilution across
the segment from glutamate to OAA (FGSMO) indicates very little
anaplerosis or exchange after succinyl-CoA. The label dilution
from citrate to OAA (FCitGSMO), as well as across a full turn of
the TCA cycle (FCitCit’), was nearly the same as from FPAcCitG.
Stepwise F ratios confirmed and cross-validated the segmental
findings (Figures 3B and 3D). Dilution of aKG can be explained at
least in part by a large unlabeled intracellular glutamate pool and
exogenous unlabeled glutamine (Supplemental Experimental
Procedures, S5; Figures S3A and S3B). Unfortunately, it is not
possible to distinguish anaplerosis from exchange by F analysis
alone. Glutamate anaplerosis requires a net loss of nitrogen
either to ammonia or urea. Consequently, metabolic exchange
is the most likely since at 9 mM glucose concentrations aspar-
tate levels are reduced (Table S5), transaminases do not
generate free ammonia, and GDH is completely inhibited by
mitochondrial GTP (Kibbey et al., 2014; Tanizawa et al., 2002).
Since there was relatively little dilution in the distal reactions of
the TCA cycle (FGS, FSM, and FMO; Figures 2F, 3C, and S2),
then glutamate is fully in exchange with aKG at a rate that is
very fast relative to the TCA cycle rate.
Both PC- and TCA-cycle-derived OAA contribute to citrate
formation. From independently calculated Fs, about 80% of
the oxidative TCA flux (green bars) contributes to citrate forma-
tion and is balanced by anaplerotic flux of 20% (orange) (Fig-
ure 3D). Interestingly, anaplerotic and oxidative Fs involving
aspartate (FPOD and FDOC) were proportionately different, sug-
gesting a different carbon flow pattern involving aspartate. At
steady state, anaplerosis is balanced by cataplerosis. Since
the Fs monitoring flow from pyruvate into OAA (orange) were
of the same magnitude as those of OAA back to pyruvate (red),
this suggests that PEPCK-M and ME are the principle catapler-
otic pathways. Taken together, the PC contribution to the TCA
cycle was confirmed to be approximately 20%. This sets a clear
upper limit to anaplerosis contributing to CS and is significantly
lower than those suggested previously (Cline et al., 2004; Lu
et al., 2002).
A side-by-side comparison of MIMOSA and NMR methods
was performed to better understand the origin of the discrep-
ancy in steady-state PC calculations. Because of the inherent
low sensitivity of NMR, glutamate isotopomers are often the
principle input to calculate fluxes relative to CS. The tcaCALC
software was originally designed to analyze metabolic fluxes
based on NMR-derived isotopomer distribution using glutamate
as the principle input (Malloy et al., 1988). In order to obtain
reasonable fits for insulin-secreting cells, tcaCALC required an
extra ‘‘pyruvate cycling’’ function (Lu et al., 2002). This ‘‘pyruvate
cycling’’ term assumes a metabolic pool of carbon flow from py-
ruvate to OAA/malate and back to PEP/pyruvate that somehowetabolism 22, 936–947, November 3, 2015 ª2015 Elsevier Inc. 939
Figure 3. Isotopic Steady-State Analysis
(A) Graphical scheme of the 52 steady-state precursor-product relationships between the metabolic intermediates contributing to the TCA cycle.
(B–D) Map and the ratio of precursor (X) to product (Y) enrichments (FX/Y) of (B) segmental, (C) serial, and (D) anaplerotic/cataplerotic reactions of the TCA cycle.
*p < 0.001; **p < 0.0001. All data are reported as mean ± SEM.does not mix with glycolytic pyruvate. While the glutamate iso-
topomers were similar using either NMR or LC-MS/MS (Fig-
ure 1E), the calculated PC and ‘‘pyruvate cycling’’ rates were
substantially higher using tcaCALC (Figure 4A). If such high ‘‘py-
ruvate cycling’’ rates were real (Lu et al., 2002), a prediction
based on the OAA/malate enrichments would be that pyruvate
M+2 enrichments would be high (approaching 22%). Direct pyru-
vate M+2 is measured at only 5%, suggesting that tcaCALC
overestimates PC.
We hypothesized that tcaCALC did not have sufficient meta-
bolic information to predict all of the metabolic fluxes from gluta-
mate isotopomers alone. The companion software of tcaCALC,
tcaSIM, simulates glutamate isotopomer distributions given
different fluxes (Jeffrey et al., 1991). If the fluxes obtained from
tcaCALC are used as tcaSIM inputs, it correctly predicts the
observed NMR isotopomer distribution (Figure 4B, blue versus
red). However, if the simulations are constrained by the direct
MIMOSA F values, the measured and predicted glutamate iso-
topomer distributions are also quite similar (Figure 4B, green).
Since there are at least two minima found by the program,
there is not a unique solution that can be calculated from
the glutamate isotopomers. Using the fluxes from tcaCALC,
tcaSIM also predicts total 13C2-pyruvate 4-fold higher than940 Cell Metabolism 22, 936–947, November 3, 2015 ª2015 Elsevierthe measured data (Figure 4C, blue versus red). MIMOSA con-
strains the predicted 13C2-pyruvate to the observed value (Fig-
ure 4C, green). Consequently, without multiple ordinates con-
straining the flux calculations, the local minimum arrived at by
tcaCALC from glutamate isotopomers is substantially different
from multiple directly measured values.
Dynamic Metabolic Modeling
A key advantage of MIMOSA flux interrogations is the broad ca-
pacity to assess time-dependent positional labeling of multiple
ordinates across the TCA cycle. Here, the flowof isotope transfer
through mitochondrial reactions was modeled mathematically
using the program CWave (Mason et al., 2003). Position-specific
(isotopomer) and position-independent (isotopologue) models
were used for such comparisons. A final model was built using
the MS-measured isotopomers through three turns of the TCA
cycle (Figure 5A, S4A, and S4B; Table S3; Supplemental Exper-
imental Procedures, S5). Both isotopologue and isotopomeric
data obtained at different labeling times were used as separate
inputs. The model was then tested for fit quality and proximity
to the results obtained from the steady-state analysis.
Using just isotopologue data, themodel severelymissed some
target data. These misses were especially prominent for theInc.
Figure 4. Comparison of Steady-State Analyses by NMR and MIMOSA
(A) VPDH, VPC, and VPK fluxes relative to VCS calculated from NMR-based tcaCALC simulations (blue) compared to equivalent MIMOSA values (F, red). Pyruvate
cycling here is denoted as 13C-label that cycles out of the TCA cycle into pyruvate via PEPCK and ME. In tcaCALC, this is the ‘‘PK’’ term but is distinct from
glycolysis. In MIMOSA, it is the transfer of OAA label to the full pyruvate pool, FOP.
(B) Measured and predicted glutamate NMR multiplet isotopomer distributions from (blue) direct, (red) predicted from tcaSIM using the tcaCALC flux values
(PDH = 1, PC = 0.409, Ys = 0.838, PK = 0.77), and (green) predicted by tcaSIM using MIMOSA-derived constraints (PDH = 1, PC = 0.15, Ys = 1, PK = 0.26).
(C) Total enrichments of 13C2-pyruvate isotopomers directly measured by LC-MS/MS (blue), predicted by tcaSIM using tcaCALC fluxes (red), or using steady-
state MIMOSA values (green). All data are reported as mean ± SEM. Predicted values by tcaSIM have no uncertainty levels reported by the software.anaplerotic-containing fragments, and in particular citrate M+3
(Figure S5A). In the absence of positional data, this poor fit
was driven by inappropriately high rates of Vbox (Figure S5B)
needed to force a dilution of the AcCoA pool. The Vbox rate
generated by the model fit is inconsistent with the direct mea-
sures of VPDH relative to VCS (FPAc) and overestimates unlabeled
AcCoA (Figures S5C and S5D). Subsequently, VCS, VPC, and py-
ruvate cycling are also overestimated (Figures S5E and S5F). By
incorporating isotopomeric inputs, the overestimation was cor-
rected and lowered these flux values (Figures 5H and S6; Sup-
plemental Experimental Procedures, S5) to match the direct
measures.
Interestingly, FAcCit is less than 1 and indicates that citrate is
being diluted from an unlabeled source. In the absence of an
exogenousanaplerotic citratepool, theonlybiologically plausible
source of the dilution is from the carboxylation of unlabeled aKG.
A consistent 13% reduction inmeasured relative to predicted cit-
rate for the four isotopomer families affected byC6 carboxylation
supports aKG as the diluting source (Table S4). Also in agree-
ment, is the time-dependent AcCoA labeling ofC4,5Pro-S citrate
that is better described by two processes: a fast component rep-
resenting VCS and amuch smaller and slower component coming
from an exchange with aKG (Figures S4C–S4F). The presence
of unlabeled glutamate first diluting aKG and then (through re-
ductive/oxidative isocitrate dehydrogenase [ICDH] exchange)
diluting citratewas detected in asymmetries of theC6-containing
isotopomers of citrate (Supplemental Experimental Procedures,
S2D). Consequently, a diluting exchange from ICDH is needed
to interpret the citrate isotopomers fully.Measuring and account-
ing for these prior to deconvolving the citrate families substan-
tially improved the model fits. Unfortunately, isotopologue-only
datasets will have these errors embedded in themwithout a priori
knowledge of the position-specific data. In the final CWave
model, fits of each oxidative and anaplerotic ordinate were supe-
rior for the isotopomers compared to the isotopologue-only
model (Figures S5A and S6). Not surprisingly, isotopomeric
data were better at predicting the enrichments of other labeled
ordinates that were not included as target data (e.g., [13C2]pyru-
vate in Figure S5F). Additionally, the SD of the distribution of
valuesattributed toVPCwasalso smaller (FigureS5G). Theoverall
least square standard deviation (LSSD) was also narrower for theCell Misotopomer data (LSSD 1.39 versus 1.44, respectively). The final
model benefitted from (1) isotopomeric citrate, OAA, AcCoA,
glutamate, succinate, and aspartate data; (2) inclusion of gluta-
mate, glutamine, and isocitrate exchanges; (3) a balancing ana-
plerosis and cataplerosis; and (4) correction for labeled citrate
C6 loss. Importantly, across the physiologic glucose range from
5–9 mM, MIMOSA can detect very small changes in VCS (8%
for p < 0.05 and 12% for p < 0.01) and VPC (37% for p <
0.05 and 60% for p < 0.01). These would impart sensitivity to
very subtle changes in metabolism given that a 1 mM increase
in glucose concentration increases VCS 40% and VPC >
200%. Taken together, the static and dynamic results highlight
the importance of using multiple positional inputs while deter-
mining metabolic fluxes.
Mitochondrial Metabolism and Insulin Secretion
As amodel system, pancreatic b-cells relate glucose-dependent
changes in metabolism to the functional output of insulin secre-
tion. The clonal insulinoma cell line INS-1 832/13 has been the
subject of many published flux experiments and has a nearly
linear release of insulin across physiologic glucose concentra-
tions (2.5 to 9 mM) (Figure 5B; Table 1) (Cline et al., 2004; Jensen
et al., 2006; Lorenz et al., 2013; Lu et al., 2002; Pongratz et al.,
2007; Stark et al., 2009). Many more metabolomics analyses
have endeavored to relate changes in the concentration of
metabolite(s) to insulin secretion. As glucose concentration
increased, the steady-state concentration of all other metabo-
lites increased by varying degrees, with the exception of aspar-
tate, which declined (Table S5). The concentrations remained
constant across the time course consistent with metabolic
steady state. Differences in concentrations and enrichments of
multiple metabolites have been used previously to infer relative
differences in metabolic fluxes. However, it is important to point
out that incorrect or incomplete conclusions can be drawn from
either in isolation. For instance, the concentration in PEP re-
mained unchanged going from 2.5 to 5 mM glucose and nearly
doubled going from 7 to 9 mM glucose (Figure 5C; Table S5).
In contrast, steady-state PEP enrichments nearly doubled over
the former, while remaining flat at the latter (Figure 5D).
Steady-state relationships alone can only detect relative
changes of one flux versus another but cannot determineetabolism 22, 936–947, November 3, 2015 ª2015 Elsevier Inc. 941
Figure 5. Relationship of MIMOSA-Modeled Mitochondrial Rates Determined by CWave to Insulin Secretion
(A) Overview of the rates and isotopomers considered in the CWave model: Pyruvate kinase (VPK); pyruvate dehydrogenase (VPDH); pyruvate carboxylase (VPC);
conversion of OAA into pyruvate (VPEP/PyrCycling); citrate/isocitrate exchange with aKG (VICDH); aKG exchange with glutamate (VGlutExc); dilution of glutamate (VGlutDil);
the racemizing exchange between the malate/fumarate; and (OAA VSC). The arrows associated with VCS have different colors indicating different turns (blue [1
st],
orange [2nd], and purple [3rd]). The isotopomers with the greatest impact are displayed next to each pool, and their carbons are color-coded to match their
associated turn of the TCA cycle.
(B) Insulin secretion from cells incubated with 2.5, 5, 7, and 9 mM glucose.
(C) [PEP] normalized to intracellular [taurine].
(D) PEP M+3 enrichments from glycolysis of glucose M+6.
(legend continued on next page)
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reaction rates. Of the mitochondrial steady-state Fs, only those
associated with PC flux (FPO and FPOCit’) and PEP/pyruvate
cycling changed proportionately with glucose (Figures 5E–5G;
Table S6), consistent with other steady-state studies (Cline
et al., 2004; Lu et al., 2002). PDH flux relative to CS (FPAc) did
not change with glucose (Figure 5H). In contrast, VCS, VPDH,
and VPC all increase with glucose (Figure 5J). Even at the highest
glucose concentration, VPC approached only 20% of VCS (Ta-
ble 1). The relative increase in PC flux exhibited a much higher
dynamic range than oxidative metabolism (Figure 5K). Addition-
ally, the ratio between VPC and VCS internally validated the model
since it was similar to FPO, (Figure 5I). Consequently, all the ab-
solute fluxes (both oxidative and anaplerotic) were strongly
correlated with insulin secretion (Figures 5L and 5M), although
VPC had amuch steeper slope (Figure 5M). Oxygen consumption
modestly increased with glucose (Table 1) and also correlated
with VCS (Figure 5N). The oligomycin-sensitive ATP component
remained surprisingly flat, suggesting that proton leak accounts
for the majority of the glucose-dependent change in respiration
(Figure 5O).
Metabolic Differences Are Dependent on Cell Type,
Nutrients, and Hormones
MIMOSA was extended to other cells, nutrient, and hormonal
conditions (Figure 6). C2C12 myoblast cells were incubated
with 5 mM [U-13C6]-D-glucose alone, under the same conditions
used for the INS-1 cells (Figure 6A), in the presence of insulin (Fig-
ure 6B) or in the presence of fatty acids (Figure 6C). VCS and VPDH
rates increased with insulin stimulation as expected (Figures 6D
and 6E). The presence of fatty acids increased Vbox with concom-
itant inhibition of VPDH (Figures 6E and 6F). Additionally, the ratios
VPDH/VCS and Vbox/VCS (Figures 6G and 6H) obtained from the dy-
namic analysis were concordant with the FPAc calculated from
steady state (Figure 6I). VPC was much slower than VPDH, Vbox,
or VCS but increased with insulin, and it was inhibited by the pres-
ence of fatty acids (Figure 6J). The same trends were observed in
the analysis of FPO, FPOM, and FPOCit (Figure 6K). Unlike in the
INS-1 cells, ICDH flux was only observed in the direction of
aKG in the C2C12 cells (Figure 6L).
In primary rat hepatocytes, a similar sequential transfer of label
from [U-13C3]-L-lactate to the TCA cycle intermediates was
observed (Figures 6M and 6N). The dynamic analysis revealed
high rates of VCS (compared to INS-1 and C2D12 cells) and a pri-
mary reliance on fatty acid oxidation (Figure 6N). VPC was only a
fraction of VCS without hormonal or substrate stimulation under
these experimental conditions.
DISCUSSION
MIMOSA is a mass spectroscopic platform to quantitate the
essential mitochondrial metabolic fluxes present in most living
cells. A key advance is the capacity for unambiguous identifica-(E–H) precursor/product relationships FPO, FPOCit, FOP, and FPAc, respectively.
(I) VPC/VCS calculated from MIMOSA rates (Table 1).
(J and K) (J) Absolute rates and (K) fold change through CS, PDH, PC, lipid oxida
(L and M) (L) Correlation between CS and (M) PDH and PC fluxes and insulin sec
(N) Correlation between O2 consumption and CS.
(O) O2 consumption from ATP synthesis and mitochondrial leak. All data are rep
Cell Mtion of NMR-validated position-specific enrichments of multiple
TCA cycle metabolites. Importantly, the positional AcCoA, OAA,
and citrate enrichments in the mitochondrial matrix were deter-
mined for direct calculation of VCS in the compartment where it
actually occurs. In addition, a comprehensive list of steady-state
intermolecular sequential and segmental isotopomeric relation-
ships assesses themultiple nodes that occur at biochemical inter-
sections distributed across oxidative, anaplerotic, exchange, and
cycling reactions. Finally, it incorporates all the positional data
into amathematic model of relevant metabolic reactions to calcu-
late the discrete metabolic flux and exchange rates.
The fully integrated method combines position-specific frag-
ment deconvolution of key intermediates, 52 sequential and
segmental steady-state relationships, and solves 182 mass and
isotope balance differential equations to calculate the fluxes.
13C NMR confirmed isotopomeric assignments, and fluxes
were cross-validated by correlation of steady-state and dynamic
measurements (both isotopologue and fragment deconvolved).
Quantitative measurements of glycolysis, pyruvate kinase, PC,
PDH, b-oxidation, CS, ICDH, PEP/pyruvate cycling (PEPCK-
M + ME), glutamate-aKG and glutamate-glutamine exchanges,
ATP synthesis, proton leak, and insulin secretion were deter-
mined as a function of glucose concentration in a b-cell model
and were extended to muscle and liver model systems.
Other models have been created to measure rates from 13C-
labeling (e.g., Quek et al., 2009; Weitzel et al., 2013). Recently,
an improved model was developed that makes use of differential
equations to describe the non-steady-state variation of 13C-en-
richments (Young, 2014). Unfortunately, these isotopologue-
based methods are limited in systems with anaplerotic meta-
bolism, especially if there is significant exchange. Similarly,
even with position-specific information from a single ordinate
such as glutamate, key fluxeswere dramatically missed. A signif-
icant advantage of MIMOSA is the ability to detect and track
position-specific transfer of label across the key mitochondrial
reactions. This proved to be essential especially regarding the
anaplerotic fluxes (Figures 4 and S5). Importantly, in an open
in vitro system exchange and/or anaplerosis of unlabeled gluta-
mate can substantially dilute not only subsequent reactions of
the TCA cycle but even citrate itself. Consequently, such isotope
dilution (or isotope transfer if labeled glutamate is used) through
aKG-citrate exchange does not imply net reductive carboxyla-
tion. In these studies, reductive carboxylation was balanced by
oxidative decarboxylation with no net reverse ICDH flux.
Another caveat identified here is the potential problem using
one metabolite as surrogate for another. For instance, aspartate
enrichments differed from malate and OAA and were excluded
from the CWave analysis (Figure 2). Similarly, the experimental
pyruvate measurements did not behave as the true precursor
of AcCoA, likely because intra and extracellular pools deter-
mined its enrichment. Caution must be used if glutamate is the
sole surrogate of AcCoA, particularly in open in vitro systemstion (b-ox), and ICDH calculated using the model.
retion.
orted as mean ± SEM. *p < 0.01, **p < 0.001.
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944 Cell Metabolism 22, 936–947, November 3, 2015 ª2015 Elsevierwhere exogenous concentrations of glutamine can dilute the
pool of glutamate. In the present work, there was no delay or
dilution between succinate and glutamate (FGS) label transfer,
indicating that the exchange rate (VGlut_exc) is much greater
than VCS, making glutamate an ideal surrogate for aKG here.
This situation may differ in some systems such as the perfused
heart (Yu et al., 1995).
There have been progressive refinements in the measurement
of intracellular metabolic fluxes through examining the meta-
bolism of radio-, spin-, and mass-labeled substrates. These all
have contributed significantly to our understanding of intracellular
metabolismand form the theoretical basis uponwhichMIMOSA is
founded. For instance, the importance of anaplerosis in insulin-
secreting b-cells was first identified using radiolabeled substrates
(MacDonald, 1993). This fluxwas later confirmed by NMR spin la-
beling tocorrelatewith insulin secretion (Clineet al., 2004;Luetal.,
2002; Simpson et al., 2006). Importantly, these studies necessi-
tated a re-evaluation of ATP production as the principle mecha-
nismswherebymitochondrial metabolism regulates rates of insu-
lin secretion. However, these techniques only provided estimates
of anaplerosis relative to VCS and not the absolute flux rate.
Without a direct measure of VCS or VPDH, it is not possible to
conclude a stronger relationship of one flux or another with insulin
secretion. Here we demonstrate strong correlations between all
the anaplerotic and oxidative rates with GSIS, making a clear
mechanistic linkage with just one more tenuous.
In these same cells, PC rates were previously estimated to
exceed the TCA cycle rate. These rates are inconsistent with
either the direct steady-state enrichments or the dynamic flux
data in the present study (Cline et al., 2004; Jensen et al.,
2006; Lu et al., 2002; Simpson et al., 2006). If indeed PC flux
were twice that of CS, then M+2 pyruvate should be at least
33%, but in actuality, it only approached 4%. MIMOSA uses
(1) natural-abundance-corrected singlet glutamate and (2) multi-
ple precursor/product pool enrichments together with (3) other
anaplerosis- and exchange-mediated dilutions in order to recali-
brate PC and carbon recycling rates. While the overall PC contri-
bution to the TCA cycle is much lower than previously estimated,
the large glucose-induced increase in VPC/VCS was confirmed.
Of note, since all of these measurements have been made at
metabolic steady state, they can only be mechanistically linked
to a PEP/pyruvate cycle involving malic enzyme and/or
PEPCK-M (Pongratz et al., 2007; Stark et al., 2009) but not cyto-
solic ICDH, as previously suggested (Jensen et al., 2006; Lu
et al., 2002; Ronnebaumet al., 2006; 2008). Since equal amounts
of isocitrate exit and return as aKG, then ICDH-1 metabolism is
not anaplerotic and is simply an extramitochondrial oxidative
loop that better correlates with VCS.
MIMOSA has the sensitivity to detect subtle changes in meta-
bolism (as little as 8%) that can be expanded into the analysis of
other cellular fluxesor conditions. Theplatformhasbroadapplica-
bility to flux measurements in any glucose-oxidizing cell (INS-1
832/13, C2C12, and hepatocytes shown here) that containsmito-
chondria. In comparison to tissue culture, in vivo systems are
closed andmore complex, since label that is metabolized in other
tissues can be incorporated into circulating substrates. In addi-
tion, disequilibrium of plasma and tissue-specific tracer enrich-
ments, metabolic zonation (especially in tissues such as liver),
and tissue-specific as well as substrate-specific times to reachInc.
Figure 6. Flux Analysis in C2C12 Myoblast Cells and Primary Rat Hepatocytes
(A–C) Evolution of 13C-label from glycolysis into the TCA cycle through PDH flux in C2C12 cells incubatedwith (A) glucose (5mM), (B) glucose and insulin (100 nM),
and (C) glucose and fatty acids (0.2 mM palmitate:oleate [1:2]).
(D–F) Absolute (D) VCS, (E) VPDH, and (F) Vbox.
(G–I) Relative contributions of (G) VPDH and (H) Vbox to VCS calculated from by CWave and (I) the equivalent with steady-state measurement FPAc.
(J and K) (J) Absolute VPC flux and (K) FPO calculated using OAA enrichments or malate and citrate as surrogate for OAA.
(L) Calculated FAcCit to assess the existence of reversed ICDH flux.
(M and N) (M) Evolution of 13C-label from [U-13C3]lactate into the TCA cycle through PC flux in primary rat hepatocytes and (N) respective fluxes calculated by
MIMOSA. Absolute fluxdata is reported asmean± SDof the fluxdistribution calculated byCWave. All other data are reported asmean± SEM. *p < 0.01; **p < 0.001.steady state shouldbeconsidered. Itwould beamistake to imme-
diately implement these studies in vivowithout a formal validation.
By taking advantage of dynamic accumulation of position-spe-
cific enrichment across multiple metabolite ordinates, MIMOSA
provides a direct measurement of mitochondrial metabolism. A
particular strength is the ability to resolve positional isotopomers
of AcCoA, OAA, and citrate in order to capture definitive CS
flux. Recently, there has been a surge in thewide-spread applica-
tion of NMR spin labeling and mass isotope labeling strategies
to assess different aspects of cellular metabolic flux (BuescherCell Met al., 2015). If interpreted correctly, these have the potential
to contribute greatly to our understanding of metabolism. Im-
portantly, conclusions about any steady-state metabolic flux
measurement could be substantially flawed without first (1) con-
firming isotopic and metabolic steady state, (2) correcting posi-
tional natural abundance enrichments, (3) assigning isotopomeric
labeling patterns, (4) considering diluting and position-modifying
exchange reactions, and (5) correlating precursor and product
relationships. Given the complexity of metabolism, the use
of orthogonal methods to cross-validate should always beetabolism 22, 936–947, November 3, 2015 ª2015 Elsevier Inc. 945
considered. When applied to a model of insulin secretion, a sig-
nificant recalibration of prior flux estimates has identified large
changes in the magnitudes of key fluxes, most notably pyruvate
carboxylase. In addition to studies of b-cell, hepatocyte, and
muscle metabolism, MIMOSA has broad applicability to poten-
tially characterize the mitochondrial metabolism of any tissue or
cell and may be helpful to solve ‘‘some of the practical problems
of medicine.’’
EXPERIMENTAL PROCEDURES
13C-Isotopomer Isotopomer Labeling Studies
Insulinoma (INS-1) 832/13 cells, primary rat hepatocytes, and C2C12 myo-
cytes were cultured as monolayers in RPMI-1640 complete medium as previ-
ously described (Kibbey et al., 2007). 13C-Isotopomer studies were performed
in in DMEM medium (D5030, Sigma-Aldrich) supplemented with glucose (2.5,
5, 7, and 9 mM), glutamine (4 mM), pyruvate (0.05 mM), and lactate (0.45 mM)
with palmitate/oleate, insulin, and BSA as described for individual experi-
ments. A metabolic steady state was reached before the addition of [U-13C6]
glucose or [U-13C3]lactate (Cambridge Isotope Laboratories) as described
(see Supplemental Experimental Procedures, S1).
LC-MS/MS Analysis
Samples were injected onto a Hypercarb column and ionized by electrospray
into an SCIEX 5500 QTRAP equipped with a SelexION for differential mobility
separation (DMS) and acquired using multiple reaction monitoring (MRM)
(Supplemental Experimental Procedures, S2A; Table S7). Endogenous
taurine, an intracellular osmolyte, was used as internal control for cell density
as previously described (Kibbey et al., 2007). 13C incorporation into taurine
did not occur under the experimental conditions nor did the absolute con-
centration of taurine change during the incubations. The atomic percent
excess (APE) was calculated and background and natural abundance
corrected from an isotopomer matrix accounting for the presence of
natural abundance carbons distributed throughout each possible parent/
daughter ion combination (Supplemental Experimental Procedures, S2A
and S2B).
NMR Analysis
The isotopomer distribution of glutamate at each carbon position was deter-
mined by 13C NMR spectroscopy with an AVANCE 500-MHz spectrometer
(Bruker Instruments, Inc.). Spectra were acquired with TR = 0.5 s, NS =
10,000, 16 K data, and Waltz-16 broadband proton decoupling. The iso-
topomer pattern obtained from the NMR analysis was used in tcaCALC to
calculate metabolic fluxes relative to CS as previously described (Cline
et al., 2004; Lu et al., 2002; Simpson et al., 2006).
Insulin Secretion
Media extracts were measured for insulin concentration using the Rat High
Range Insulin ELISA kit (ALPCO) per manufacturer’s instructions. All media ex-
tracts were normalized to cell protein concentration using aMicro-BCAProtein
Assay Kit (Pierce).
Isotopomer Analysis
Assumptions
The analysis of metabolic fluxes was preceded by the following assumptions:
(1) For the deconvolution of citrate isotopomers, only three turns of the TCA
cycle were considered (Figure 1A). This assumption was confirmed by the low
percentage of citrate M+1 expected in the third cycle.
(2) In an open system, bicarbonate does not contribute significantly to the
labeling patterns.
(3) For calculating citrate and glutamate isotopomers, pyruvate is consid-
ered predominantly either M+0 or M+3. M+2 pyruvate from PC-mediated pyru-
vate recycling will be mostly [2,3-13C2]pyruvate and will label AcCoA the same
as M+3. Other M+1- and M+2-labeled pyruvate will make an insignificant contri-
bution (as confirmed by the low enrichments).
(4) Acetyl-CoA only contributes carbons to the Pro-S carbons of citrate.946 Cell Metabolism 22, 936–947, November 3, 2015 ª2015 Elsevier(5) For the analysis of citrate, aspartate, and OAA enrichments, OAA and
fumarate are assumed to be in near equilibrium. Therefore, for any given iso-
topomer of aspartate, OAA, and malate, there is an equal percentage of the
symmetrical isotopomer. This was confirmed by the modeling fluxes (VSC >>
VCS; Table 1; Figure S7) and by
13C-NMR analysis of glutamate C3 and C2
(C3/C2 = 0.96 ± 0.06).
Deconvolution of Citrate Isotopomers
The principles and derivation of mass isotopomeric deconvolution for the indi-
cated metabolites are described in Supplemental Experimental Procedures,
S2C–S2H. The enrichments of citrate isotopomers were calculated from the
191/67 fragment according to Equations 2–11. Prior to the calculation of citrate
isotopomer families, the citrate spectrum was corrected for C6 loss from
reversible exchange across ICDH.
Calculation of Acetyl-CoA and OAA Enrichments
The fractional enrichments of themitochondrial matrix pool of AcCoA andOAA
were calculated using MIDA (Hellerstein and Neese, 1992). Enrichments were
calculated from either glutamate or citrate isotopomers according to the
description in Supplemental Experimental Procedures, S3.
Steady-State Flux Analysis
Steady-state (Fx) analysis was performed to identify sites of anaplerosis and
exchange at intersecting metabolic nodes based on the quotient of product
and precursor enrichments (derivations and equations in Supplemental Exper-
imental Procedures, S4; Table S2).
Metabolic Model for Flux Analysis
The time courses of 13C-labelingwere fit with amathematical model of the TCA
cycle (described in Supplemental Experimental Procedures, S5). The model
describes the labeling of the pyruvate pool from a glycolytic precursor and
the entry of carbons into the TCA cycle via the PDH and PC reactions using
[U-13C3]PEP as a driving function. The label is distributed through all possible
isotopomers for citrate, aKG, glutamate, succinate, malate, and OAA. The iso-
topomers were grouped in combination pools based on the number and/or po-
sition of labeled carbons and used to fit target data. As target data we used the
following time course: [U-13C3]pyruvate, Cita,f,i,d,h,,j, Cita, Citf, Cith+i, and Citj;
total label in glutamate-C4,5; and 13C2-,
13C3-,
13C4-succinate, malate, and
OAA. The mass balance and isotope rate equations are shown (Supplemental
Experimental Procedures, S5). Metabolic modeling was performed using
CWave software, version 3.0 (Mason et al., 2003) running in MATLAB version
R2014b with OS X version 10.9.4. The distributions of uncertainty were calcu-
lated using a Monte-Carlo analysis with 20 repetitions (Patel et al., 2010).
Oxygen Consumption Measurements
Oxygen consumption of INS-1 cells was measured in DMEM media, similar to
the described above and according to the protocol previously described (Wik-
strom et al., 2012). Cells were incubated with 2.5 mM glucose for 1 hr before
the addition of glucose to a final concentration of 2.5, 5, 7, or 9 mM. Cellular
respiration was perturbed at indicated times during the assay by the addition
of oligomycin (5 mM), FCCP (1 mM), and a mixture of rotenone (5 mM) and anti-
mycin A (10 mM).
Statistical Analysis
All data are reported as mean ± SEM. Comparisons of metabolic parameters
were made by a one-way ANOVA corrected for multiple comparisons using
Dunnett’s test. Differences were considered to be significant at p < 0.05.
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